Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Endovascular therapy for acute ischemic stroke increased modestly in use before dropping last year, analysis of Get With The Guidelines-Stroke hospitals showed. A big boost is expected after the recent spate of positive trials.

The American Heart Association is teaming up with Medtronic on a recurrent cryptogenic stroke reduction initiative.

In related news, Medtronic featured real-world use of its Reveal LINQ insertable cardiac monitor for atrial fibrillation detection in cryptogenic stroke patients at the AHA’s International Stroke Conference.

Related issued on Stroke

Venous thromboembolism prophylaxis is recommended for all stroke patients with weakness in new recommendations released at the ISC from the nonprofit Physician-Patient Alliance for Health and Safety.

CardioBreak is a guide to what’s new and interesting on the Web for cardiologists and other healthcare professionals with an interest in cardiovascular disease, powered by the MedPage Today community. Got a tip? Send it to us: c.phend@medpagetoday.com.

SOURCE

http://www.medpagetoday.com/Cardiology/Strokes/50048?isalert=1&uun=g99985d3527R5099207u&utm_source=breaking-news&utm_medium=email&utm_campaign=breaking-news&xid=NL_breakingnews_2015-02-16

Other articles published in this Open Access Online Scientific Journal include the following:

Stroke – Ten Big Factors, Heart Rate No Predictor of Second Stroke

http://pharmaceuticalintelligence.com/2012/08/27/stroke-ten-big-factors-heart-rate-no-predictor-of-second-stroke/